ImmunityBio Stock (NASDAQ: IBRX) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 2.259K / 7.413M |
Day Range | - - - |
52 Wk Range | 1.250 - 10.530 |
Market Cap | $5.429B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 55 |
Short Interest | 35.26% |
Days to Cover | 3.23 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of ImmunityBio (NASDAQ: IBRX) through any online brokerage.
Other companies in ImmunityBio’s space includes: Immunovant (NASDAQ:IMVT), Legend Biotech (NASDAQ:LEGN), Ultragenyx Pharmaceutical (NASDAQ:RARE), Ionis Pharmaceuticals (NASDAQ:IONS) and Cerevel Therapeutics Hldg (NASDAQ:CERE).
The latest price target for ImmunityBio (NASDAQ: IBRX) was reported by Piper Sandler on Monday, April 29, 2024. The analyst firm set a price target for 6.00 expecting IBRX to fall to within 12 months (a possible -23.57% downside). 2 analyst firms have reported ratings in the last year.
The stock price for ImmunityBio (NASDAQ: IBRX) is $7.85 last updated Today at May 17, 2024 at 5:38 AM EDT.
There are no upcoming dividends for ImmunityBio.
ImmunityBio’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
There is no upcoming split for ImmunityBio.
ImmunityBio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.